Boston Scientific Pursues Dual Strategy In Addressing RotaLink Recall
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific may opt to restart production of its original Rotablator atherectomy system following the Aug. 6 recall of the next-generation RotaLink Plus, the company reported at a same-day teleconference.